Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.53 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7681782 | 0.93 | FAAH (0.44) | FAAHCNR1CNR2ALDH1A1NAAA | |
| SCHEMBL14645473 | 0.92 | FAAH (0.49) | FAAHCNR1CNR2ALDH1A1NAAA | |
| SCHEMBL182927 | 0.92 | FAAH (0.49) | FAAHCNR1CNR2ALDH1A1NAAA | |
| SCHEMBL7685932 | 0.92 | FAAH (0.49) | FAAHCNR1CNR2ALDH1A1NAAA | |
| SCHEMBL5570199 | 0.84 | FAAH (0.41) | FAAHCNR1CNR2ALDH1A1NAAA | |
| SCHEMBL17717765 | 0.84 | FAAH (0.51) | FAAHCNR1CNR2ALDH1A1NAAA | |
| SCHEMBL18558890 | 0.84 | FAAH (0.51) | FAAHCNR1CNR2ALDH1A1NAAA | |
| SCHEMBL17717737 | 0.84 | FAAH (0.51) | FAAHCNR1CNR2ALDH1A1NAAA | |
| SCHEMBL7681787 | 0.84 | FAAH (0.41) | FAAHCNR1CNR2ALDH1A1NAAA | |
| SCHEMBL31470621 | 0.84 | FAAH (0.54) | FAAHCNR1CNR2ALDH1A1NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6384279-B1 | OXIDIZING A DIAMIDODIOL TO FORM A DIACID FOLLOWED BY COUPLING WITH AN ARYL DIAMINE | THE CLOROX COMPANY | 2002-05-07 | — | — | US | disclosed |
| US-20020028970-A1 | SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL | THE CLOROX COMPANY | 2002-03-07 | — | — | US | disclosed |
| US-6297400-B1 | CHELATING AGENTS FOR IMPROVED WASHFASTNESS OF DYE WHEN IN A BLEACHING ENVIRONMENT | THE CLOROX COMPANY | 2001-10-02 | — | — | US | disclosed |
| WO-2001002343-A1 | IMPROVED SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL | THE CLOROX COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028970-A1 | SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL | DDT, DDC, MLYCD | FAAH 2554/4885CNR1 1142/4885CNR2 706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.